These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
128 related items for PubMed ID: 25446423
1. Optimal imaging surveillance schedules after liver-directed therapy for hepatocellular carcinoma. Boas FE, Do B, Louie JD, Kothary N, Hwang GL, Kuo WT, Hovsepian DM, Kantrowitz M, Sze DY. J Vasc Interv Radiol; 2015 Jan; 26(1):69-73. PubMed ID: 25446423 [Abstract] [Full Text] [Related]
8. Single-session combined therapy with chemoembolization and radiofrequency ablation in hepatocellular carcinoma less than or equal to 5 cm: a preliminary study. Kang SG, Yoon CJ, Jeong SH, Kim JW, Lee SH, Lee KH, Kim YH. J Vasc Interv Radiol; 2009 Dec; 20(12):1570-7. PubMed ID: 19879777 [Abstract] [Full Text] [Related]
9. Downstaging disease in patients with hepatocellular carcinoma outside of Milan criteria: strategies using drug-eluting bead chemoembolization. Green TJ, Rochon PJ, Chang S, Ray CE, Winston H, Ruef R, Kreidler SM, Glueck DH, Shulman BC, Brown AC, Durham J. J Vasc Interv Radiol; 2013 Nov; 24(11):1613-22. PubMed ID: 24060436 [Abstract] [Full Text] [Related]
10. Radiofrequency ablation combined with chemoembolization: treatment of recurrent hepatocellular carcinomas after hepatectomy. Takaki H, Yamakado K, Sakurai H, Nakatsuka A, Shiraki K, Isaji S, Takeda K. AJR Am J Roentgenol; 2011 Aug; 197(2):488-94. PubMed ID: 21785099 [Abstract] [Full Text] [Related]
16. Combination therapy of chemoembolization and radiofrequency ablation for the treatment of hepatocellular carcinoma in the caudate lobe. Fujimori M, Takaki H, Nakatsuka A, Uraki J, Yamanaka T, Hasegawa T, Shiraki K, Takei Y, Yamakado K. J Vasc Interv Radiol; 2012 Dec; 23(12):1622-8. PubMed ID: 23177108 [Abstract] [Full Text] [Related]
17. [Transarterial chemoembolization plus computed tomography-guided percutaneous radiofrequency ablation for small hepatocellular carcinoma in special locations]. Guo YJ, Huang WS, Zhou B, Chen JW, Cai MY, Qian JS, Huang MS, Shan H, Zhu KS. Zhonghua Yi Xue Za Zhi; 2013 Sep 03; 93(33):2627-30. PubMed ID: 24360041 [Abstract] [Full Text] [Related]
18. Risk factors for the local recurrence of hepatocellular carcinoma after a single session of percutaneous radiofrequency ablation. Hori T, Nagata K, Hasuike S, Onaga M, Motoda M, Moriuchi A, Iwakiri H, Uto H, Kato J, Ido A, Hayashi K, Tsubouchi H. J Gastroenterol; 2003 Sep 03; 38(10):977-81. PubMed ID: 14614605 [Abstract] [Full Text] [Related]
19. Survival in patients with recurrent hepatocellular carcinoma after primary hepatectomy: comparative effectiveness of treatment modalities. Ho CM, Lee PH, Shau WY, Ho MC, Wu YM, Hu RH. Surgery; 2012 May 03; 151(5):700-9. PubMed ID: 22284764 [Abstract] [Full Text] [Related]
20. Transarterial chemoembolization using drug eluting beads and subsequent percutaneous MR-guided radiofrequency ablation in the therapy of intermediate sized hepatocellular carcinoma. Hoffmann R, Rempp H, Syha R, Ketelsen D, Pereira PL, Claussen CD, Clasen S. Eur J Radiol; 2014 Oct 03; 83(10):1793-8. PubMed ID: 25052871 [Abstract] [Full Text] [Related] Page: [Next] [New Search]